Hoppa till sidans huvudinnehåll
Investment and innovation in drug research and development (R&D) for highly prevalent chronic diseases has stalled in recent decades, despite half of all Americans living with at least one chronic disease. As a result, prevalent chronic diseases are producing immense health care costs as well as preventable suffering and death. On February 22, March 2, and March 8, 2021, the National Academies of Sciences, Engineering, and Medicine, convened a workshop to discuss barriers to innovation in this space and examine strategies and incentives to support equitable, person-centered drug R&D for prevalent chronic diseases.

Produktinformation

  • Utgivningsdatum2021-12-17
  • Mått152 x 229 x undefined mm
  • FormatHäftad
  • SpråkEngelska
  • Antal sidor112
  • FörlagNational Academies Press
  • ISBN9780309092142

Tillhör följande kategorier

Hoppa över listan

Mer från samma författare

Hoppa över listan

Du kanske också är intresserad av